Cargando…
Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naïve Crohn’s Disease: A Case Series
Prospective trials of anti-mycobacterial antibiotic therapy (AMAT) have proven efficacious in Crohn’s disease (CD) but use as first-line treatment in CD has not been evaluated. This paper reports the outcomes of patients with CD treated with first-line AMAT. This paper consists of a case series of t...
Autores principales: | Agrawal, Gaurav, Clancy, Annabel, Sharma, Rijata, Huynh, Roy, Ramrakha, Sanjay, Borody, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142403/ https://www.ncbi.nlm.nih.gov/pubmed/32155771 http://dx.doi.org/10.3390/microorganisms8030371 |
Ejemplares similares
-
Profound remission in Crohn’s disease requiring no further treatment for 3–23 years: a case series
por: Agrawal, Gaurav, et al.
Publicado: (2020) -
Anti-Mycobacterial Antibiotic Therapy Induces Remission in Active Paediatric Crohn’s Disease
por: Agrawal, Gaurav, et al.
Publicado: (2020) -
Crohn’s strictures open with anti-mycobacterial antibiotic therapy: A retrospective review
por: Collyer, Rhys, et al.
Publicado: (2020) -
Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease
por: Agrawal, Gaurav, et al.
Publicado: (2015) -
Putting Crohn’s on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn’s Disease
por: Agrawal, Gaurav, et al.
Publicado: (2020)